Emily Symington

Consultant Haematologist
Cambridge University Hospitals NHS Foundation Trust
Cambridge, England, United Kingdom

Presentation(s):

• OC 30.1 - Seven-year follow-up of valoctocogene roxaparvovec gene therapy for haemophilia A

  Monday, June 24, 2024
  09:30 – 09:45 ICT

• OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1

  Monday, June 24, 2024
  09:45 – 10:00 ICT